Cardioprotective glucose-lowering drugs, statins, and risk of first-time atherosclerotic cardiovascular disease in Denmark: a nationwide cohort study.

Ternhamar T, Johansen MØ, Nordestgaard BG, Afzal S

Open source

DOI
10.1016/j.lanepe.2025.101490
Published
2025 Dec
Container
The Lancet regional health. Europe
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanepe.2025.101490,
  title = {Cardioprotective glucose-lowering drugs, statins, and risk of first-time atherosclerotic cardiovascular disease in Denmark: a nationwide cohort study.},
  author = {Ternhamar T and Johansen MØ and Nordestgaard BG and Afzal S},
  year = {2025},
  journal = {The Lancet regional health. Europe},
  doi = {10.1016/j.lanepe.2025.101490},
  url = {https://doi.org/10.1016/j.lanepe.2025.101490}
}

RIS

TY  - JOUR
TI  - Cardioprotective glucose-lowering drugs, statins, and risk of first-time atherosclerotic cardiovascular disease in Denmark: a nationwide cohort study.
AU  - Ternhamar T
AU  - Johansen MØ
AU  - Nordestgaard BG
AU  - Afzal S
PY  - 2025
JO  - The Lancet regional health. Europe
DO  - 10.1016/j.lanepe.2025.101490
UR  - https://doi.org/10.1016/j.lanepe.2025.101490
ER  - 

APA

T, T., MØ, J., BG, N., & S, A. (2025). Cardioprotective glucose-lowering drugs, statins, and risk of first-time atherosclerotic cardiovascular disease in Denmark: a nationwide cohort study.. The Lancet regional health. Europe. https://doi.org/10.1016/j.lanepe.2025.101490

Source records